A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)

Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
12/2002
12/12/2002	WO2002098352A2 PHARMACEUTICAL COMPOSITIONS FOR THE COORDINATED DELIVERY OF NSAIDs
12/12/2002	WO2002098351A2 Novel method and composition for inhibition of angiogenesis and tumor growth using compounds based on a sequence within mmp-2
12/12/2002	WO2002098278A2 Peripheral blood fibrocytes differentiation pathway and migration to wound sites
12/12/2002	WO2002083879A3 Immunotherapy based on dendritic cells
12/12/2002	WO2002076508B1 Methods for delivering nucleic acid molecules into cells and assessment thereof
12/12/2002	WO2002074798A3 The genome of a bifidobacterium
12/12/2002	WO2002072548A3 Heterocyclic compounds and their use as histamine h4 ligands.
12/12/2002	WO2002067848A3 PEPTIDES FROM THE 16/6id ANTIBODY FOR TREATING SLE
12/12/2002	WO2002066458A3 2-thio-substituted imidazole derivatives and the use thereof in the pharmaceutical industry
12/12/2002	WO2002064591A3 Carboline derivatives
12/12/2002	WO2002064080A3 Matrix metalloproteinase inhibitors
12/12/2002	WO2002062792A9 Jnk inhibitor
12/12/2002	WO2002058620A3 Pharmaceutical compositions containing a cox-ii inhibitor and a muscle relaxant
12/12/2002	WO2002030983A3 Plasma fraction containing bikunin, method for the production thereof and use of the same
12/12/2002	WO2002029044A3 Modulation of the transcription of pro-inflammatory gene products
12/12/2002	WO2002018593A3 Modulation of fas and fasl expression
12/12/2002	WO2002002775A3 Calpain protease 12
12/12/2002	WO2001097850A3 Combinations and compositions which interfere with vegf/vegf and angiopoietin/tie receptor function and their use (ii)
12/12/2002	US20020188142 17-Side chain alkynyl-and 20-oxopregna-derivatives of vitamin D, methods for their production and pharmaceutical compositions thereof
12/12/2002	US20020188134 Pharmaceutical compositions
12/12/2002	US20020188124 Novel spiro compounds
12/12/2002	US20020188122 Such as pyridine-4-carboxaldehyde-(4-Morpholinylprop-3-yl) imine for use in therapy as cytokine inhibitors
12/12/2002	US20020188118 Compounds and methods for the inhibition of the expression of VCAM-1
12/12/2002	US20020188100 Boron compound for use in the treatment of stroke, heart defects, inflammation, autoimmune and cancer disease
12/12/2002	US20020188017 Thienylazolylalkoxyethanamines, their preparation and their application as medicaments
12/12/2002	US20020188009 Bisarylimidazolyl fatty acid amide hydrolase inhibitors
12/12/2002	US20020188006 4-hydroxypiperidine derivatives having antiarrhythmic activity
12/12/2002	US20020187999 Anti-inflammatory uses of manzamines
12/12/2002	US20020187998 Local ophthalmic agent for treatment of ocular inflammation
12/12/2002	US20020187996 Prevention of addiction in pain management
12/12/2002	US20020187991 Barbituric acid derivatives
12/12/2002	US20020187984 Pharmaceutical uses and synthesis of diketopiperazines
12/12/2002	US20020187978 4-Heteroaryl-3-heteroarylidenyl-2-indolinones and their use as protein kinase inhibitors
12/12/2002	US20020187947 Inflammation-related gene
12/12/2002	US20020187941 Pregabalin lactose conjugates
12/12/2002	US20020187934 Peptide derivatives
12/12/2002	US20020187523 Extracellular signaling molecules
12/12/2002	US20020187492 Nucleotide sequences coding polypeptides for use in the treatnment of inflammation
12/12/2002	US20020187140 Two novel human cathepsin proteins
12/12/2002	CA2449771A1 Novel benzothienyl or indole derivatives, and use thereof as inhibitors of prenyl transferase proteins
12/12/2002	CA2449770A1 Novel anti-infectives
12/12/2002	CA2449487A1 Sphingosine kinase interacts with traf2 and modulates tumor necrosis factor-induced cellular activity
12/12/2002	CA2449466A1 Peripheral blood fibrocytes differentiation pathway and migration to wound sites
12/12/2002	CA2449109A1 2-heteroaryl-imidazotriazinones and their use in the treatment of inflammatory or immune diseases
12/12/2002	CA2449097A1 5-ethyl-imidazotriazinones
12/12/2002	CA2449095A1 Imidazotriazinones derivatives and their use against inflammatory processes and/or immune diseases
12/12/2002	CA2449021A1 Novel compounds and compositions as cathepsin inhibitors
12/12/2002	CA2448828A1 Novel method and composition for inhibition of angiogenesis and tumor growth using compounds based on a sequence within mmp-2
12/12/2002	CA2448665A1 Sustained-release analgesic compounds
12/12/2002	CA2448606A1 Nucleic acid-associated proteins
12/12/2002	CA2448418A1 Chemical compounds and pharmaceutical compositions as cathepsin s inhibitors
12/12/2002	CA2446696A1 Cyclic nucleotide phosphodiesterase inhibitors, preparation and uses thereof
12/12/2002	CA2445460A1 Carboline derivatives as pde-5 inhibitors
12/12/2002	CA2438099A1 Trifluoromethylpurines as phosphodiesterase 4 inhibitors
12/11/2002	WO2002000231A1 Use of a formulation made of or containing at least one dissimilated milk serum
12/11/2002	WO2001083471A1 Novel indole derivatives exhibiting chymase-inhibitory activities and process for preparation thereof
12/11/2002	EP1264829A1 Oxygen-containing heterocyclic compounds
12/11/2002	EP1264827A1 Process for the preparation of Tosylbenzylformamides
12/11/2002	EP1264597A2 Methods and compositions for treating cancer
12/11/2002	EP1263982A1 Phosphatidyl serine receptors and uses thereof
12/11/2002	EP1263978A2 Inflammation-inducible hybrid promoters, vectors containing same and uses thereof
12/11/2002	EP1263960A2 Anti-tissue factor antibodies with enhanced anticoagulant potency
12/11/2002	EP1263959A1 Antibodies to human cd154
12/11/2002	EP1263940A1 Protein tyrosine phosphatase polynucleotides, polypeptides, and antibodies
12/11/2002	EP1263933A2 Treatment for bone disorders
12/11/2002	EP1263791A2 Human g-protein chemokine receptor (ccr5) hdgnr10
12/11/2002	EP1263786A2 Methods and compositions for immunoregulation
12/11/2002	EP1263776A2 Peptides targeting specifically tumor-derived endothelial cells
12/11/2002	EP1263766A1 Adam polynucleotides, polypeptides, and antibodies
12/11/2002	EP1263760A1 Novel compounds
12/11/2002	EP1263759A2 Azaindoles
12/11/2002	EP1263758A2 3-(diarylmethylene)-8-azabicyclo[3.2.1]octane derivatives
12/11/2002	EP1263757A1 Benzthiazoles as tnf and pde-iv inhibitors
12/11/2002	EP1263756A2 Beta-amino acid derivatives as inhibitors of matrix metalloproteases and tnf-alpha
12/11/2002	EP1263755A2 Cyclic beta-amino acid derivatives as inhibitors of matrix metalloproteases and tnf-alpha
12/11/2002	EP1263743A1 Heterocycle substituted diphenyl leukotriene antagonists
12/11/2002	EP1263740A1 Pyrimidine-4-one derivatives as ldl-pla2 inhibitors
12/11/2002	EP1263737A1 2-phenylcarbamoyl-benzimidazoles
12/11/2002	EP1263736A1 2-carboxamide-benzimidazoles useful in the treatment and prevention of ischemic reperfusion injury
12/11/2002	EP1263732A1 Corticotropin releasing factor antagonists
12/11/2002	EP1263730A1 Amine derivatives for the treatment of apoptosis
12/11/2002	EP1263728A2 Pde iv inhibiting amides, compositions and pharmaceutical use
12/11/2002	EP1263725A1 Novel compounds
12/11/2002	EP1263724A1 Novel compounds
12/11/2002	EP1263721A1 Pharmaceutical compositions containing 3-amino-azetidine derivatives, novel derivatives and preparation thereof
12/11/2002	EP1263719A1 N-deacetylthiocolchine derivatives and pharmaceutical compositions containing them
12/11/2002	EP1263718A1 Novel use of phenylheteroalkylamine derivatives
12/11/2002	EP1263715A1 Novel phenylheteroalkylamine derivatives
12/11/2002	EP1263714A1 Novel phenylheteroalkylamine derivatives
12/11/2002	EP1263711A1 Novel use of phenylheteroalkylamine derivatives
12/11/2002	EP1263467A1 Improved paste formulations
12/11/2002	EP1263464A1 Use of tgf-beta antagonists to treat or to prevent loss of renal function
12/11/2002	EP1263430A2 Treatment of diseases associated with cytokine production with inhibitors of the tec family of protein tyrosine kinases
12/11/2002	EP1263427A1 Il-8 receptor antagonists
12/11/2002	EP1263425A1 Use of comt inhibitors as analgesics
12/11/2002	EP1124535B1 Preservative system for topically administrable pharmaceutical compositions containing a fatty acid/amino acid soap
12/11/2002	EP1071433B1 2',2'-difluoronucleosides for immunosuppressive therapy and combined pharmaceutical compositions
12/11/2002	EP1017378B1 Amide derivatives for the treatment of diseases mediated by cytokines
12/11/2002	EP0984943B1 Azacyclooctane and heptane derivatives, their preparation and usein therapy
12/11/2002	EP0981521B1 Novel macrocyclic compounds as metalloprotease inhibitors

1 ... 884 885 886 887 888 889 890 891 892 893 894 895 896 897 898 899 900 901 902 903 904 ... 1272